SIGA Technologies
SIGA
#9009
Rank
A$0.30 B
Marketcap
A$4.18
Share price
-5.40%
Change (1 day)
-68.95%
Change (1 year)

Earnings for SIGA Technologies (SIGA)

Earnings in 2026 (TTM): A$32.1 Million

According to SIGA Technologies's latest financial reports the company's current earnings are A$93.77 Million. In 2025 the company made an earning of A$33.22 Million a decrease over its 2024 earnings that were of A$98.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SIGA Technologies from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$32.1 M-3.37%
2025 A$33.22 M-66.13%
2024 A$98.1 M-16.31%
2023 A$0.11 B89.48%
2022 A$61.86 M-50.38%
2021 A$0.12 B16.22%
2020 A$0.10 B1268.64%
2019 A$7.83 M-98.69%
2018 A$0.59 B-1912.24%
2017 -A$33.04 Million-7.91%
2016 -A$35.88 Million-30.38%
2015 -A$51.53 Million-82.62%
2014 -A$0.3 Billion796.54%
2013 -A$33.07 Million5.18%
2012 -A$31.44 Million-28.53%
2011 -A$44 Million
2009 -A$16.66 Million35.95%
2008 -A$12.25 Million17.07%
2007 -A$10.47 Million9.58%
2006 -A$9.55 Million168.94%
2005 -A$3.55 Million-71.48%
2004 -A$12.45 Million67.71%
2003 -A$7.43 Million57.35%
2002 -A$4.72 Million3.73%
2001 -A$4.55 Million-54.2%
2000 -A$9.93 Million105.09%
1999 -A$4.85 Million-33.58%
1998 -A$7.29 Million477.78%
1997 -A$1.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
A$34.29 M 18.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$90.37 Million-412.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion-1,597.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.35 Million-139.21%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.64 Billion-2,300.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.84 M 186.39%๐Ÿ‡บ๐Ÿ‡ธ USA